- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/08 - 1,3-OxazinesHydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Patent holdings for IPC class C07D 265/08
Total number of patents in this class: 27
10-year publication summary
|
0
|
3
|
1
|
1
|
3
|
0
|
2
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4440 |
6 |
| F. Hoffmann-La Roche AG | 7808 |
4 |
| Pliant Therapeutics, Inc. | 66 |
3 |
| Shionogi & Co., Ltd. | 883 |
3 |
| Siena Biotech S.p.A. | 33 |
3 |
| The Regents of the University of California | 20815 |
1 |
| Infineum International Limited | 454 |
1 |
| Nihon Nohyaku Co., Ltd. | 327 |
1 |
| Nissan Chemical Industries, Ltd. | 1638 |
1 |
| Universiteit Gent | 1411 |
1 |
| University of Kwazulu-natal | 45 |
1 |
| Olene Life Sciences Private Limited | 25 |
1 |
| Shanghai ChemPartner Co., Ltd. | 3 |
1 |
| Other owners | 0 |